Nuclear Receptors and Clock Components in Cardiovascular Diseases - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue International Journal of Molecular Sciences Année : 2021

Nuclear Receptors and Clock Components in Cardiovascular Diseases

Résumé

Cardiovascular diseases (CVD) are still the first cause of death worldwide. Their main origin is the development of atherosclerotic plaque, which consists in the accumulation of lipids and inflammatory leucocytes within the vascular wall of large vessels. Beyond dyslipidemia, diabetes, obesity, hypertension and smoking, the alteration of circadian rhythms, in shift workers for instance, has recently been recognized as an additional risk factor. Accordingly, targeting a pro-atherogenic pathway at the right time window, namely chronotherapy, has proven its efficiency in reducing plaque progression without affecting healthy tissues in mice, thus providing the rationale of such an approach to treat CVD and to reduce drug side effects. Nuclear receptors are transcriptional factors involved in the control of many physiological processes. Among them, Rev-erbs and RORs control metabolic homeostasis, inflammatory processes and the biological clock. In this review, we discuss the opportunity to dampen atherosclerosis progression by targeting such ligand-activated core clock components in a (chrono-)therapeutic approach in order to treat CVD.
Fichier principal
Vignette du fichier
ijms-22-09721.pdf (1.09 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Licence : CC BY - Paternité

Dates et versions

inserm-04435658 , version 1 (02-02-2024)

Licence

Paternité

Identifiants

Citer

Benoit Pourcet, Hélène Duez. Nuclear Receptors and Clock Components in Cardiovascular Diseases. International Journal of Molecular Sciences, 2021, 22 (18), pp.9721. ⟨10.3390/ijms22189721⟩. ⟨inserm-04435658⟩
24 Consultations
4 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More